Biology 9700 · AS & A Level · Genetic technology applied to medicine

Genetic technology applied to medicine — practice question

Many tumours secrete a protein growth factor called VEGF. This chemical messenger makes nearby blood vessels sprout new branches into the tumour, and the monoclonal antibody bevacizumab (Avastin®) binds specifically to VEGF.
(a)[2]

Suggest how Avastin® can stop a tumour from growing and spreading.

(b(i))[1]

State the antigen injected into a mouse to make this monoclonal antibody.

(b(ii))[1]

State what is meant by a hybridoma.

(c)[3]

The monoclonal antibody produced by the hybridoma method is altered to make humanised mouse antibody. This antibody molecule is similar to those made by humans. Suggest advantages of using humanised mouse antibody instead of mouse antibody.

(d)[2]

A second monoclonal antibody, ranibizumab (Lucentis®), is used to treat eye conditions. Lucentis® is a fragment of Avastin® and is shown in Fig. 2.1. Complete Fig. 2.1 so that it shows a molecule of Avastin®. Labels are not needed.

Worked solution & mark scheme

This 9-mark question has a full step-by-step worked solution and mark scheme. One marking point: prevents formation of new blood vessels to tumour

  • Full mark scheme, point by point
  • Step-by-step worked solution
  • Write your answer & get it marked instantly by AI